- Home
- LRHC vs AEON Comparison
LRHC vs AEON Comparison
Compare LRHC & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRHC
- AEON
- Stock Information
- Founded
- LRHC 2004
- AEON N/A
- Country
- LRHC United States
- AEON United States
- Employees
- LRHC N/A
- AEON N/A
- Industry
- LRHC
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- LRHC
- AEON Health Care
- Exchange
- LRHC Nasdaq
- AEON Nasdaq
- Market Cap
- LRHC 8.4M
- AEON 8.0M
- IPO Year
- LRHC 2023
- AEON N/A
- Fundamental
- Price
- LRHC N/A
- AEON $0.92
- Analyst Decision
- LRHC
- AEON Strong Buy
- Analyst Count
- LRHC 0
- AEON 1
- Target Price
- LRHC N/A
- AEON $7.20
- AVG Volume (30 Days)
- LRHC 24.4K
- AEON 139.8K
- Earning Date
- LRHC 11-19-2025
- AEON 11-12-2025
- Dividend Yield
- LRHC N/A
- AEON N/A
- EPS Growth
- LRHC N/A
- AEON N/A
- EPS
- LRHC N/A
- AEON N/A
- Revenue
- LRHC $78,037,079.00
- AEON N/A
- Revenue This Year
- LRHC N/A
- AEON N/A
- Revenue Next Year
- LRHC N/A
- AEON N/A
- P/E Ratio
- LRHC N/A
- AEON N/A
- Revenue Growth
- LRHC 54.92
- AEON N/A
- 52 Week Low
- LRHC $4.33
- AEON $0.38
- 52 Week High
- LRHC $142.40
- AEON $115.57
- Technical
- Relative Strength Index (RSI)
- LRHC N/A
- AEON 73.70
- Support Level
- LRHC N/A
- AEON $0.78
- Resistance Level
- LRHC N/A
- AEON $0.85
- Average True Range (ATR)
- LRHC 0.00
- AEON 0.04
- MACD
- LRHC 0.00
- AEON 0.02
- Stochastic Oscillator
- LRHC 0.00
- AEON 100.00
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.